ME Dem Senate Candidate on Platner: That Nazi Oyster Farmer Accused of Rape...
Abigail Spanberger Gets Lit Up Over Her Energy Affordability Lies
If Your Ideology Requires the Silencing of Dissidents, Your Ideology Is Dangerous (and...
Elissa Slotkin Admits Why the Democrats Really Oppose the SAVE America Act
Ted Cruz Remembers His Dear Friend Lindsey Graham
Thanks for Proving 'Banned Books' Was a Lie, Dua Lipa
Never Forget the Media's Despicable Response to the Butler Assassination Attempt
Illness, Death and Turmoil Change Face of GOP Senate
What in the World Is Going on With Haley Stevens
Here's How Apple and Google Helped Keep Graham Platner's Campaign Alive
Trump Just Gave a Huge Update on Iran
'It's Not Extreme': Guess What the DSA Wants to Abolish Now
Texas Is About to Take on Birth Tourism
Rebecca Cooke Sold Herself As an Outsider While Profiting From Democratic Political Consul...
'Disgusting Ideology': Brandon Gill Blasts DEI Policies in Joint Committee Hearing
Tipsheet

Trump Takes Aim at Gain-of-Function Research in Latest Executive Order

Trump Takes Aim at Gain-of-Function Research in Latest Executive Order
AP Photo/Evan Vucci

President Trump signed an executive order on Monday ending current and future federal funding for gain-of-function research in certain countries, such as China and Iran.

Advertisement

The order seeks to protect Americans from this type of “dangerous” research and any lab accidents and biosecurity incidents that most likely caused the COVID-19 pandemic.

American innovation will not be impeded by the order, according to the White House, but it will increase the safety and security of biological research in the U.S.

  • For decades, policies overseeing gain-of-function research on pathogens, toxins, and potential pathogens have lacked adequate enforcement, transparency, and top-down oversight. Researchers have not acknowledged the legitimate potential for societal harms that this kind of research poses.
  • The Biden Administration allowed dangerous gain-of-function research with insufficient levels of oversight and actively approved Federal life-science research funding in China and other countries.
  • The 2024 United States Government Policy for Oversight of Dual Use Research of Concern and Pathogens with Enhanced Pandemic Potential (“DURC/PEPP”) and the 2024 Framework for Nucleic Acid Synthesis Screening are the latest examples of inadequate policies that rely on self-reporting and fail to protect Americans from dangerous research practices.
  • This Order pauses research using infectious pathogens and toxins in the United States that may pose a danger to American citizens until a safer, more enforceable, and transparent policy governing such research can be developed and implemented. It directs the Director of the Office of Science and Technology Policy (OSTP) and the National Security Advisor (NSA) to work with funding agencies to develop such a policy within 120 days.
  • Unlike previous policies, this Order contains enforcement and reporting mechanisms that will strengthen oversight and discourage subjective interpretation of policies that researchers have used in the past to evade biosafety and biosecurity oversight. (White House)
Advertisement

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement